228 related articles for article (PubMed ID: 6286749)
1. Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay.
Vitti P; Valente WA; Ambesi-Impiombato FS; Fenzi GF; Pinchera A; Kohn LD
J Endocrinol Invest; 1982; 5(3):179-82. PubMed ID: 6286749
[TBL] [Abstract][Full Text] [Related]
2. Graves' IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: a clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease.
Marcocci C; Valente WA; Pinchera A; Aloj SM; Kohn LD; Grollman EF
J Endocrinol Invest; 1983 Dec; 6(6):463-71. PubMed ID: 6689493
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease.
Marcocci C; Vitti P; Lopez G; Santini F; Mammoli C; Fenzi GF; Pinchera A
Clin Endocrinol (Oxf); 1989 Feb; 30(2):109-19. PubMed ID: 2575468
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay.
Vitti P; Rotella CM; Valente WA; Cohen J; Aloj SM; Laccetti P; Ambesi-Impiombato FS; Grollman EF; Pinchera A; Toccafondi R; Kohn LD
J Clin Endocrinol Metab; 1983 Oct; 57(4):782-91. PubMed ID: 6136523
[TBL] [Abstract][Full Text] [Related]
5. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
[TBL] [Abstract][Full Text] [Related]
6. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of cyclic AMP and iodide accumulation responses to thyroid-stimulating immunoglobulins in cultured FRTL-5 cells.
Bidey SP; Ekins RP
Clin Endocrinol (Oxf); 1986 Apr; 24(4):447-58. PubMed ID: 2874907
[TBL] [Abstract][Full Text] [Related]
8. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
[TBL] [Abstract][Full Text] [Related]
9. Graves' immunoglobulin G stimulates iodothyronine 5'-deiodinating activity in FRTL-5 rat thyroid cells.
Toyoda N; Nishikawa M; Horimoto M; Yoshikawa N; Mori Y; Yoshimura M; Masaki H; Tanaka K; Inada M
J Clin Endocrinol Metab; 1990 Jun; 70(6):1506-11. PubMed ID: 1971826
[TBL] [Abstract][Full Text] [Related]
10. Graves' immunoglobulin G stimulates iodide efflux in FRTL-5 thyroid cells.
Shoda Y; Kondo Y; Kobayashi I
J Clin Endocrinol Metab; 1993 Jul; 77(1):94-7. PubMed ID: 8100833
[TBL] [Abstract][Full Text] [Related]
11. Thyroid stimulating immunoglobulins: measurement and clinical use.
Ollis CA; Tomlinson S; Munro DS
Clin Sci (Lond); 1985 Aug; 69(2):113-21. PubMed ID: 2866060
[No Abstract] [Full Text] [Related]
12. [Studies on the thyrotropin receptor and adenylate cyclase activity in various thyroid diseases: I. The properties of TSH receptor and adenylate cyclase in Graves' thyroid and retro-orbital adipose tissues (author's transl)].
Abe Y
Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):739-53. PubMed ID: 6248386
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
14. Increase of thyroid stimulating activity in Graves' immunoglobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay.
Inui T; Kouki T; Yamashiro K; Hachiya T; Ochi Y; Kajita Y; Sato Y; Nagata A
Thyroid; 1998 Apr; 8(4):319-25. PubMed ID: 9588497
[TBL] [Abstract][Full Text] [Related]
15. TSH binding by globulins from patients with Graves' disease.
Bíró J
Endocrinol Exp; 1981; 15(2):145-53. PubMed ID: 6114853
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of the binding of Graves' immunoglobulins by the patients own and other thyroid membranes.
Gossage AA; Byfield PG; Copping S; Himsworth RL
Clin Endocrinol (Oxf); 1981 Mar; 14(3):301-10. PubMed ID: 6894892
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of thyrotropin-stimulated adenylate cyclase activation and growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema: comparison with activities of thyrotropin-binding inhibitor immunoglobulins.
Cho BY; Shong YK; Lee HK; Koh CS; Min HK
Acta Endocrinol (Copenh); 1989 Jan; 120(1):99-106. PubMed ID: 2563181
[TBL] [Abstract][Full Text] [Related]
18. Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor.
Vitti P; Elisei R; Tonacchera M; Chiovato L; Mancusi F; Rago T; Mammoli C; Ludgate M; Vassart G; Pinchera A
J Clin Endocrinol Metab; 1993 Feb; 76(2):499-503. PubMed ID: 8094393
[TBL] [Abstract][Full Text] [Related]
19. An investigation of the ability of TSH and Graves' immunoglobulin G to increase intracellular calcium in human thyroid cells, rat FRTL-5 thyroid cells and eukaryotic cells transfected with the human TSH receptor.
MacNeil S; Munro DS; Metcalfe R; Cotterell S; Ruban L; Davies R; Weetman AP
J Endocrinol; 1994 Dec; 143(3):527-40. PubMed ID: 7836899
[TBL] [Abstract][Full Text] [Related]
20. Untreated Graves' but not remission Graves' immunoglobulin G preparations increase intracellular Ca2+ in FRTL-5 thyroid cells.
Kuwabara A; Okajima F; Akiyama H; Kobayashi I; Kondo Y
Endocr J; 1996 Oct; 43(5):457-67. PubMed ID: 8980884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
